Author/Authors :
Effatpanah, Hosein Research Center for Molecular Medicine - Hamadan University of Medical Sciences , Yadegarazari, Reza Research Center for Molecular Medicine - Hamadan University of Medical Sciences , Karami, Manoochehr Research Center and Dept. of Biostatistics and Epidemiology - Hamadan University of Medical Sciences , Majlesi, Amir Dept. of Gastrointestinal Disease - Beheshti Hospital of Hamadan University of Medical Sciences , Shabab, Nooshin Research Center for Molecular Medicine - Hamadan University of Medical Sciences , Saidijam, Massoud Research Center for Molecular Medicine - Hamadan University of Medical Sciences
Abstract :
Background: Early detection is a key to survival for gastric cancer. Molecular markers such as miRNA
(microRNA) can have great importance in the early diagnosis of gastric cancer. Expression of miR-21 and miR-221
are deregulated in many types of human cancers. This study aimed to investigate the differences in miRNA
expression patterns within the Iranian population. Methods: Total RNA was extracted from gastric cancer tissues
and adjacent non-cancerous tissues from 32 patients. Expression levels of miR-21 and miR-221 were detected by
Real time RT-PCR using a specific primer, with 5s rRNA as the internal reference gene. Results: Our data showed
that the expression levels of miR-21 and miR-221 in gastric cancer samples were significantly higher than in paired
non-cancerous samples (P < 0.05). The receiver operating characteristic (ROC) analyses yielded the area under the
curve (AUC) values of 80.30 for miR-21 and 93.30 for miR-221, and combined ROC analysis revealed the highest
AUC value of 96.90 in discriminating GC patients from healthy controls. Conclusion: It seems that miR-21 and
miR-221 expression pattern in Iranian patients with gastric cancer are similar to any other population. Considering
the increased expression level of two miRNAs in cancerous tissue compared to normal tissue as well as the area
under ROC curve, miR-21 and miR-221 can be used for early detection of gastric cancer. Iran. Biomed. J. 19 (4):
188-193, 2015